Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
2.685 USD | +2.48% | +1.33% | +14.38% |
03:04pm | VYNE Therapeutics Says US FDA Clears its Investigational New Drug Application for Potential Autoimmune Treatment | MT |
04-04 | Transcript : VYNE Therapeutics Inc. - Special Call |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+14.38% | 36.94M | |
+28.50% | 662B | |
+22.23% | 546B | |
-4.93% | 359B | |
+16.97% | 323B | |
+4.08% | 289B | |
+13.68% | 234B | |
+3.84% | 198B | |
-10.35% | 194B | |
+3.98% | 167B |
- Stock Market
- Equities
- VYNE Stock
- News VYNE Therapeutics Inc.
- Insider Trends: Insider Sales Add to 90-Day Trend at VYNE Therapeutics